Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 63

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 63
---
VATIONS FUND II, LP (“MW XO II”) in the 2025 September PIPE and (ii) 31,250 ADSs/ordinary shares issuable upon the exercise of Warrants purchased by MW XO II in the 2025 September PIPE. Marshall Wace, LLP is the investment manager of MW EUREKA FUND, and Marshall Wace North America L.P. is the investment manager of MW XO II. No individual has ultimate beneficial ownership of the shares owned by such stockholders. The address of Marshall Wace LLP is George House, 131 Sloane Street, London SW1X 9AT, United Kingdom and the address of Marshall Wace North America L.P. is 350 Park Avenue, New York, NY 10022.

(9)

Consists of (i) 97,688 ADSs/ordinary shares purchased by Soleus Capital Master Fund, L.P. (“Soleus Capital Master Fund”) in open market transactions following the 2025 September PIPE and held as of October 17, 2025, (ii) 70,312 ADSs/ordinary shares purchased by Soleus Capital Master Fund in the 2025 September PIPE and (iii) 70,312 ADSs/ordinary shares issuable upon the exercise of Warrants purchased by Soleus Capital Master Fund in the 2025 September PIPE. Soleus Capital, LLC is the sole general partner of Soleus Capital Master Fund; Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC; Soleus Capital Management, L.P. (“Soleus Capital Management”) is the investment manager for Soleus Capital Master Fund; and Soleus GP, LLC is the sole general partner of Soleus Capital Management. Guy Levy is the sole managing member of Soleus Capital Group, LLC and Soleus GP, LLC. Each of Soleus Capital, LLC, Soleus Capital Group, LLC, Soleus Capital Management, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus Capital Master Fund except to the extent of their pecuniary interest therein. The address for each of these entities and individual is 100 Field Point Road, Suite 200, Greenwich, CT 06830.

<div align='center'>43</div>

TABLE OF CONTENTS

### PLAN OF DISTRIBUTION
The Selling Shareholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling ordinary shares (or ADSs represented